0 CHECKOUT

PRODUCT FILTERS

REGION

111
101
101
99
99

COUNTRY

99
3
2
2
2

PRICE

22
49
114
266

PUBLISHED

30
82
168
266

PRODUCT TYPE

252
6
5
2
1

Leukemia Drugs

On average over 40,000 are diagnosed with leukemia each year in the United States. It is also one of the most common cancers in children. Large differences in therapeutic outcomes exist among patient groups such as children and old age sufferers, and according to the form of a disease that has many variants such as Acute (AML) and Chronic (CML) Myelocytic Leukemia, Acute (ALL) and Chronic (CLL) Lymphocytic Leukemia, and Hairy Cell Leukemia (HCL). These variations have led to unmet needs among specific patient groups. The selection of expert and insightful reports in this section enable you explore these market opportunities by providing key industry data such as drug development strategies, international market trends and forecasts and profiles of major players like Novartis, Pfizer and Bristol-Myers Squibb. Show Less Read more

Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019

About Chronic Lymphocytic Leukemia Chronic lymphocytic leukemia is a malignant condition characterized by increased production of lymphocytes. It has been observed that the cancer first affects B-lymphocytes...

Published:  August 2015
Price:  From

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

About Acute Myeloid Leukemia Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor...

Published:  December 2014
Price:  From

Global and Chinese Idarubicin Hydrochloride Industry - 2016

The 'Global and Chinese Idarubicin Hydrochloride Industry - 2016' is a professional and in-depth study on the current state of the global Idarubicin Hydrochloride industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Decitabine (CAS2353-33-5) Industry - 2016

The 'Global and Chinese Decitabine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Decitabine industry with a focus on the Chinese market....

Published:  April 2016
Price:  From

Global and Chinese Decitabine Industry - 2016

The 'Global and Chinese Decitabine Industry - 2016' is a professional and in-depth study on the current state of the global Decitabine industry with a focus on the Chinese market. The report provides...

Published:  April 2016
Price:  From

Global and Chinese Dexamethasone dipropionate (CAS 55541-30-5) Industry - 2016

The 'Global and Chinese Dexamethasone dipropionate Industry - 2016' is a professional and in-depth study on the current state of the global Dexamethasone dipropionate industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Dexamethasone Palmitate Industry - 2016

The 'Global and Chinese Dexamethasone Palmitate Industry, - 2016' is a professional and in-depth study on the current state of the global Dexamethasone Palmitate industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Dexamethasone-17-acetate (CAS 1177-87-3) Industry - 2016

The 'Global and Chinese Dexamethasone-17-acetate Industry, - 2016' is a professional and in-depth study on the current state of the global Dexamethasone-17-acetate industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Triamcinolone (CAS 124-94-7) Industry - 2016

The 'Global and Chinese Triamcinolone Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Triamcinolone industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – Pipeline Forecast & Market Forecast in G8 Countries (2011 – 2020)

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential with increasing incidence rate of the disease across the globe The incidence of acute lymphocytic/lymphoblastic...

Published:  December 2013
Price:  From

Treating Refractory Hematological Malignancies – Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Emerging Therapeutics

Targeting unmet needs in the treatment of cancer through innovative drug development strategies have witnessed favourable outcomes recently New targets have been validated in this process where kinases...

Published:  August 2013
Price:  From

Dasatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

CAS Cytarabine hydrochloride World Consumption Report

This CAS Cytarabine hydrochloride World Consumption Report provides data on the net consumption of CAS 69-74-9 - Cytarabine hydrochloride Substance(s) in each of the countries listed. The Substance(s)...

Published:  May 2016
Price: 

CAS Cytarabine World Consumption Report

This CAS Cytarabine World Consumption Report provides data on the net consumption of CAS 147-94-4 - Cytarabine Substance(s) in each of the countries listed. The Substance(s) covered (Cytarabine ) are...

Published:  May 2016
Price: 

Clofarabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

Dasatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

Clofarabine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

Nelarabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

Nelarabine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 

Global and Chinese Cytarabine (CAS 147-94-4) Industry - 2016

The 'Global and Chinese Cytarabine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Cytarabine industry with a focus on the Chinese market....

Published:  April 2016
Price:  From
Loading Indicator

Our Clients